Showing results (41-50 of 284) with videos related to
Sort By:
Pageof 29
Molecular and Cellular Neurosciences|June 17, 2015
Oxygen regulates proliferation of neural stem cells through Wnt/β-catenin signallingLena Braunschweig, Anne K Meyer, Lisa Wagenführ, et al.Journal of Parkinson'S Disease|May 7, 2014
Sleep disorders in Parkinson's diseaseWiebke Schrempf, Moritz D Brandt, Alexander Storch, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 21, 2019
Epileptic seizures and outcome in different subtypes of subarachnoid haemorrhage - Results of a single-center retrospective analysisMatthias Wittstock, Kyrylo Kurtieiev, Annette Grossmann, et al.Neurochemistry International|November 8, 2002
Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicityHeike Blessing, Markus Bareiss, Heinz Zettlmeisl, et al.Journal of Neurochemistry|June 22, 2006
Neurotoxic mechanisms of 2,9-dimethyl-beta-carbolinium ion in primary dopaminergic cultureJuliane Hamann, Hans Rommelspacher, Alexander Storch, et al.Frontiers in Neurology|October 16, 2018
Atrophy of the Vagus Nerve in Parkinson's Disease Revealed by High-Resolution UltrasonographyUwe Walter, Panagiota Tsiberidou, Maxi Kersten, et al.Cell and Tissue Research|March 11, 2010
"Silenced" polydendrocytes: a new cell type within the oligodendrocyte progenitor cell population?Andreas Hermann, Moritz D Brandt, Kai F Loewenbrück, et al.Journal of Parkinson'S Disease|June 23, 2026
Agreement between relatives of Parkinson's patients and clinical observer in home diary assessmentsCarin Janz, Jonathan Timpka, Alexander Storch, et al.Journal of Chemical Neuroanatomy|November 6, 2003
Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cellsAlexander Storch, Henry A Lester, Bernhard O Boehm, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case reportMatthias Löhle, Wiebke Schrempf, Martin Wolz, et al.Pageof 29